The impact factor places it in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology, AACC said.

It noted that Clinical Chemistry has disseminated essential research on all aspects of coronavirus testing and a broad range of medical conditions.

A journal's impact factor is determined using the number of citations received in that year by articles published in the journal during the two preceding years, and is calculated by Clarivate Analytics (formerly known as Thomson Reuters).

BrightInsight launches digital diagnostics platform at AACC
BrightInsight on Monday announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab...

LumiraDx to discuss microfluidic technology at AACC
LumiraDx announced that it will host an industry workshop at AACC 2022 on Wednesday, describing the impact of its microfluidic technology on lateral-flow...

Cytovale to present new data on rapid sepsis test at AACC
Cytovale said Monday that it will present new data at AACC 2022 about its 10-minute IntelliSep test for sepsis and its associated system.

Companies announce new products ahead of AACC 2022
Several companies have announced the launch of laboratory diagnostic products in advance of AACC 2022.

DiaSorin nabs FDA clearance for infectious disease blood test
Saluggia, Italy-based DiaSorin on Friday announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for the Liaison MeMed BV, its...

Survey finds low morale among lab professionals
Lighthouse Lab Services on Wednesday announced the results of its first wage and morale survey of medical laboratory professionals, saying that despite...

Beckman, Scopio to partner on blood smear platforms
Beckman Coulter Diagnostics on Wednesday announced that it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral...